GSK3β influences cancer cell proliferation largely through its modulation of oncogenic pathways, most notably the Wnt/β-catenin signaling pathway, wherein it phosphorylates β-catenin, resulting in its proteasomal degradation and subsequent inhibition of cell proliferation [7,8]. Here, GSK3B is linked to cancer.